Russia Unveils Enteromix, a Personalised mRNA Cancer Vaccine with 100% Efficacy in Early Trials, Paving the Way for Breakthroughs in Precision Oncology and Patient-Specific Treatment
By Team VOH
In a groundbreaking development that could transform oncology, Russian researchers have introduced Enteromix